Trial Profile
Clinical Trials Insight: 700040272
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 05 Jan 2009
Price :
$35
*
At a glance
- Drugs Preladenant (Primary)
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Sponsors Merck & Co
- 05 Jan 2009 New trial record.